The Research About Acute Compartment Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
fasciotomy: if it was suspected with ACS, the fasciotomy was conducted. but if the blister observed, it means decreased conmpartment sydrome. therefore, the blister observed can avoid unnecessary fasciotomy to patients suspected with ACS
Study summary
Acute compartment syndrome (ACS) is defined as a clinical entity originated from trauma or other conditions, and remains challenging to diagnose and treat effectively. Threre is the controversy in diagnosing, treating ACS. It was found that there was no criterion about the ACS, and result unnecessary osteotomy. The presence of clinical assessment (5P) always means the necrosis of muscles and was the most serious or irreversible stage of ACS. Besides pressure methods, the threshold of pressure identifying ACS was also controversial.
Eligibility
Primary outcome measure(s)
- injury mechanism — up to 1 weeks
The relative data was collected about injury mechanism such as high falling accident, traffic accident, fall from standing height,Crushing - the time when the blister appeared — up to 4 weeks
The relative data was collected about the time when the blister appeared after injury - time to reconstructive surgery — time to when the surgery was conducted after 2 weeks
The relative data was collected about time to reconstructive surgery - union time — through study completion, an average of 1 year
The relative data was collected about union time - No non-anatomic gap or step (larger than 5 mm) — through study completion, an average of 1 year
The relative data was collected about complications - secondary loss of reduction — through study completion, an average of 1 year
The relative data was collected about complications - Deep venous thrombosis — through study completion, an average of 1 year
The relative data was collected about complications - superficial wound problems — through study completion, an average of 1 year
The relative data was collected about complications - blister skin immunochemistry and immunofluorescence analysis — through study completion, an average of 1 year
CK1, 5, 10, claudin 1, 2 and occludin as determined by immunochemistry analysis, and skin barrier proteins; claudin 1, 2 and occludin was determined by immunofluorescence analysis and qPCR.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| the Third Hospital of Hebei Medical University | Shijiazhuang | Hebei | Recruiting |
More Hebei Medical University Third Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04529330 on ClinicalTrials.gov ↗ ← All trials in China